An insulin-sensitizing thiazolidinedione, which minimally activates PPARγ, does not cause bone loss

Tomohiro Fukunaga, Wei Zou, Nidhi Rohatgi, Jerry R. Colca, Steven L. Teitelbaum

Research output: Contribution to journalArticle

24 Scopus citations

Fingerprint Dive into the research topics of 'An insulin-sensitizing thiazolidinedione, which minimally activates PPARγ, does not cause bone loss'. Together they form a unique fingerprint.

Medicine & Life Sciences